A
ISSUER//CIK 0000861838
Aceragen, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K303.9 KBAceragen, Inc.Aug 16, 4:07 PM ET·0001104659-23-092550
- SC 13D/A132.2 KBAceragen, Inc.Aug 3, 4:59 PM ET·0001193125-23-202969
- 8-K197.5 KBAceragen, Inc.Jul 21, 4:05 PM ET·0001104659-23-083038
- SC 13D/A115.3 KBAceragen, Inc.Jul 17, 7:30 AM ET·0001193125-23-187666
- 8-K716.2 KBAceragen, Inc.Jul 11, 5:06 PM ET·0001104659-23-080018
- 10-Q7.7 MBAceragen, Inc.Jun 29, 4:30 PM ET·0001558370-23-011603
- 8-K243.7 KBAceragen, Inc.May 30, 4:30 PM ET·0001104659-23-066071
- 8-K213.3 KBAceragen, Inc.May 4, 8:52 AM ET·0001104659-23-055819
- 10-K13.1 MBAceragen, Inc.Apr 13, 4:31 PM ET·0001558370-23-005875
- SC 13D/A106.9 KBAceragen, Inc.Apr 10, 4:40 PM ET·0001193125-23-096589
Insiders
10- 14159, L.P.Director
- 667, L.P.Director
- Arbeit Robert D.VP Clinical Development
- Arcudi III Louis JChief Financial Officer
- Baker Biotech Capital (GP), LLC10% Owner
- Baker Bros. Advisors (GP) LLCDirector
- BAKER BROS. ADVISORS LPDirector
- Baker Bros. Capital (GP), LLC10% Owner
- Baker Brothers Life Sciences LPDirector
- BAKER FELIXDirector
Tickers
No tickers on record
Addresses
business
505 EAGLEVIEW BOULEVARD SUITE 212
EXTON, PA, 19341
mailing
505 EAGLEVIEW BOULEVARD SUITE 212
EXTON, PA, 19341
Former Names
- IDERA PHARMACEUTICALS, INC.2023-01-13
- HYBRIDON INC2005-09-02